Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Q/C TECHNOLOGIES, INC. Merger & Acquisition 2020

Nov 18, 2020

35313_rns_2020-11-18_f6afb318-14b8-4f81-bddb-5d9d32990e1d.zip

Merger & Acquisition

Open in viewer

Opens in your device viewer

Filed by Akers Biosciences, Inc.

Pursuant to Rule 425 of the Securities Act of 1933

and deemed filed pursuant to Rule 14a-12

of the Securities Exchange Act of 1934

Subject Company: MyMD Pharmaceuticals, Inc.

Commission File No.: 001-36268

Field: Page; Sequence: 1

Field: /Page

Field: Page; Sequence: 2

Field: /Page

Field: Page; Sequence: 3

Field: /Page

Field: Page; Sequence: 4

Field: /Page

Field: Page; Sequence: 5

Field: /Page

Field: Page; Sequence: 6

Field: /Page

Field: Page; Sequence: 7

Field: /Page

Field: Page; Sequence: 8

Field: /Page

Field: Page; Sequence: 9

Field: /Page

Field: Page; Sequence: 10; Options: Last

Field: /Page